þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 04-3387530 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
311 Arsenal Street Watertown, Massachusetts | 02472 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer þ | Accelerated filer ¨ | |
Non-accelerated filer ¨ | Smaller reporting company ¨ | |
Emerging growth company ¨ |
PART I – FINANCIAL INFORMATION | Page | |
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
PART II – OTHER INFORMATION | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
Item 1. | Condensed Consolidated Financial Statements (unaudited) |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2018 | 2017 (1) | 2018 | 2017 (1) | |||||||||||||
Revenue | $ | 329.5 | $ | 304.6 | $ | 982.2 | $ | 891.1 | ||||||||
Cost of revenue (2) | 154.4 | 144.0 | 460.4 | 432.2 | ||||||||||||
Gross profit | 175.1 | 160.6 | 521.8 | 458.9 | ||||||||||||
Other operating expenses: | ||||||||||||||||
Selling and marketing | 47.6 | 61.8 | 146.2 | 192.5 | ||||||||||||
Research and development (2) | 50.9 | 44.8 | 147.5 | 130.0 | ||||||||||||
General and administrative | 38.4 | 35.4 | 104.7 | 104.5 | ||||||||||||
Total other operating expenses | 136.9 | 142.0 | 398.4 | 427.0 | ||||||||||||
Operating income | 38.2 | 18.6 | 123.4 | 31.9 | ||||||||||||
Other expense | (1.8 | ) | (1.4 | ) | (6.8 | ) | (4.3 | ) | ||||||||
Income before income tax provision | 36.4 | 17.2 | 116.6 | 27.6 | ||||||||||||
Income tax provision | 10.0 | 4.2 | 22.7 | 6.1 | ||||||||||||
Net income | $ | 26.4 | $ | 13.0 | $ | 93.9 | $ | 21.5 | ||||||||
Foreign currency translation adjustment | (0.7 | ) | (0.1 | ) | (1.5 | ) | 0.3 | |||||||||
Comprehensive income | $ | 25.7 | $ | 12.9 | $ | 92.4 | $ | 21.8 | ||||||||
Net income per share – Basic | $ | 0.65 | $ | 0.33 | $ | 2.32 | $ | 0.54 | ||||||||
Net income per share – Diluted | $ | 0.64 | $ | 0.32 | $ | 2.28 | $ | 0.53 | ||||||||
Weighted average shares used in computing net income per share: | ||||||||||||||||
Basic | 40.5 | 39.9 | 40.4 | 39.8 | ||||||||||||
Diluted | 41.2 | 40.7 | 41.2 | 40.6 |
September 30, 2018 | December 31, 2017 (1) | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 303.4 | $ | 165.1 | ||||
Accounts receivable, net | 167.4 | 169.5 | ||||||
Contract assets | 79.9 | — | ||||||
Prepaid expenses and other current assets | 63.7 | 46.8 | ||||||
Total current assets | 614.4 | 381.4 | ||||||
Property and equipment, net | 337.0 | 355.1 | ||||||
Capitalized software costs, net | 154.7 | 139.7 | ||||||
Purchased intangible assets, net | 96.6 | 108.6 | ||||||
Goodwill | 281.3 | 274.4 | ||||||
Deferred tax assets, net | 1.1 | 41.8 | ||||||
Other assets (2) | 103.9 | 31.3 | ||||||
Total assets | $ | 1,589.0 | $ | 1,332.3 | ||||
Liabilities & Stockholders’ Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable (3) | $ | 2.9 | $ | 10.6 | ||||
Accrued compensation | 112.0 | 94.7 | ||||||
Accrued expenses (3) | 52.0 | 51.5 | ||||||
Current portion of long-term debt | 25.8 | 20.2 | ||||||
Deferred revenue | 31.3 | 30.7 | ||||||
Total current liabilities | 224.0 | 207.7 | ||||||
Deferred rent, net of current portion | 30.1 | 29.3 | ||||||
Long-term debt, net of current portion | 232.3 | 252.6 | ||||||
Deferred tax liability, net | 27.6 | — | ||||||
Deferred revenue, net of current portion | 0.8 | 46.5 | ||||||
Other long-term liabilities | 6.3 | 4.7 | ||||||
Total liabilities | 521.1 | 540.8 | ||||||
Commitments and contingencies (Note 1) | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.01 par value: 5.0 shares authorized; no shares issued and outstanding at September 30, 2018 and December 31, 2017 | — | — | ||||||
Common stock, $0.01 par value: 125.0 shares authorized; 40.6 shares issued and outstanding at September 30, 2018; 40.1 shares issued and outstanding at December 31, 2017 | 0.4 | 0.4 | ||||||
Additional paid-in capital | 687.2 | 646.7 | ||||||
Accumulated other comprehensive loss | (1.9 | ) | (0.4 | ) | ||||
Retained earnings | 382.2 | 144.8 | ||||||
Total stockholders’ equity | 1,067.9 | 791.5 | ||||||
Total liabilities and stockholders’ equity | $ | 1,589.0 | $ | 1,332.3 |
Nine Months Ended September 30, | ||||||||
2018 | 2017 (1) | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net income | $ | 93.9 | $ | 21.5 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization of property, equipment, capitalized software, and purchased intangible assets | 112.0 | 109.3 | ||||||
Amortization of deferred commissions and contract fulfillment costs | 6.1 | — | ||||||
Deferred income tax | 20.0 | 4.2 | ||||||
Stock-based compensation expense | 38.5 | 42.5 | ||||||
Other reconciling adjustments | 6.4 | (0.1 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 2.5 | (2.2 | ) | |||||
Contract assets | (2.5 | ) | — | |||||
Prepaid expenses and other current assets | (16.9 | ) | (8.6 | ) | ||||
Deferred commissions and contract fulfillment costs and other long-term assets | (23.9 | ) | (6.8 | ) | ||||
Accounts payable | (6.7 | ) | 0.6 | |||||
Accrued expenses, deferred rent, and other long-term liabilities | 9.2 | 2.0 | ||||||
Accrued compensation | 12.0 | (4.0 | ) | |||||
Deferred revenue | 7.7 | 2.4 | ||||||
Net cash provided by operating activities | 258.3 | 160.8 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Capitalized software costs | (64.9 | ) | (59.3 | ) | ||||
Purchases of property and equipment | (31.9 | ) | (66.8 | ) | ||||
Payments on acquisitions, net of cash acquired | (10.1 | ) | (41.1 | ) | ||||
Other investing activities | 3.5 | — | ||||||
Net cash used in investing activities | (103.4 | ) | (167.2 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from issuance of common stock under stock plans | 15.6 | 13.4 | ||||||
Taxes paid related to net share settlement of stock awards | (15.9 | ) | (17.1 | ) | ||||
Payments on long-term debt | (15.0 | ) | (15.0 | ) | ||||
Other financing activities | 0.1 | 0.1 | ||||||
Net cash used in financing activities | (15.2 | ) | (18.6 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (1.4 | ) | 0.3 | |||||
Net increase (decrease) in cash and cash equivalents | 138.3 | (24.7 | ) | |||||
Cash and cash equivalents at beginning of period | 165.1 | 147.4 | ||||||
Cash and cash equivalents at end of period | $ | 303.4 | $ | 122.7 | ||||
Non-cash transaction | ||||||||
Property, equipment, and purchased and internally-developed software recorded in accounts payable, accrued expenses, and accrued compensation | $ | 15.0 | $ | 17.5 | ||||
Additional disclosures | ||||||||
Cash paid for interest, net | $ | 5.0 | $ | 4.5 | ||||
Cash paid for taxes | $ | 11.6 | $ | 1.1 |
Cumulative Effect of Adoption Impact of New Revenue Standard January 1, 2018 | ||||
Contract assets | $ | 77.4 | ||
Deferred tax assets, net | (40.9 | ) | ||
Other assets (1) | 61.5 | |||
Total assets | $ | 98.0 | ||
Deferred revenue, current | (8.1 | ) | ||
Deferred revenue, net of current portion | (44.8 | ) | ||
Deferred tax liability, net | 7.4 | |||
Retained earnings | 143.5 | |||
Total liabilities and stockholders’ equity | $ | 98.0 |
Three Months Ended September 30, 2018 | ||||||||||||
As Presented | Impact of New Revenue Standard | Previous Revenue Standard | ||||||||||
Revenue | $ | 329.5 | $ | 1.9 | $ | 331.4 | ||||||
Cost of revenue | 154.4 | 3.7 | 158.1 | |||||||||
Gross profit | 175.1 | 1.8 | 173.3 | |||||||||
Other operating expenses: | ||||||||||||
Selling and marketing | 47.6 | 4.6 | 52.2 | |||||||||
Research and development | 50.9 | — | 50.9 | |||||||||
General and administrative | 38.4 | — | 38.4 | |||||||||
Total other operating expenses | 136.9 | 4.6 | 141.5 | |||||||||
Operating income | 38.2 | 6.4 | 31.8 | |||||||||
Other expense | (1.8 | ) | — | (1.8 | ) | |||||||
Income before income tax provision | 36.4 | 6.4 | 30.0 | |||||||||
Income tax provision | 10.0 | 1.5 | 8.5 | |||||||||
Net income | $ | 26.4 | $ | 4.9 | $ | 21.5 | ||||||
Foreign currency translation adjustment | (0.7 | ) | — | (0.7 | ) | |||||||
Comprehensive income | $ | 25.7 | $ | 4.9 | $ | 20.8 | ||||||
Net income per share – Basic | $ | 0.65 | $ | 0.12 | $ | 0.53 | ||||||
Net income per share – Diluted | $ | 0.64 | $ | 0.12 | $ | 0.52 |
Nine Months Ended September 30, 2018 | ||||||||||||
As Presented | Impact of New Revenue Standard | Previous Revenue Standard | ||||||||||
Revenue | $ | 982.2 | $ | 1.4 | $ | 983.6 | ||||||
Cost of revenue | 460.4 | 11.8 | 472.2 | |||||||||
Gross profit | 521.8 | 10.4 | 511.4 | |||||||||
Other operating expenses: | ||||||||||||
Selling and marketing | 146.2 | 12.4 | 158.6 | |||||||||
Research and development | 147.5 | — | 147.5 | |||||||||
General and administrative | 104.7 | — | 104.7 | |||||||||
Total other operating expenses | 398.4 | 12.4 | 410.8 | |||||||||
Operating income | 123.4 | 22.8 | 100.6 | |||||||||
Other expense | (6.8 | ) | — | (6.8 | ) | |||||||
Income before income tax provision | 116.6 | 22.8 | 93.8 | |||||||||
Income tax provision | 22.7 | 5.6 | 17.1 | |||||||||
Net income | $ | 93.9 | $ | 17.2 | $ | 76.7 | ||||||
Foreign currency translation adjustment | (1.5 | ) | — | (1.5 | ) | |||||||
Comprehensive income | $ | 92.4 | $ | 17.2 | $ | 75.2 | ||||||
Net income per share – Basic | $ | 2.32 | $ | 0.42 | $ | 1.90 | ||||||
Net income per share – Diluted | $ | 2.28 | $ | 0.42 | $ | 1.86 |
Previous Revenue Standard | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Business services | $ | 322.7 | $ | 295.8 | $ | 959.6 | $ | 867.1 | ||||||||
Implementation and other | 8.7 | 8.8 | 24.0 | 24.0 | ||||||||||||
Total revenue | $ | 331.4 | $ | 304.6 | $ | 983.6 | $ | 891.1 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Cost of revenue | $ | 21.2 | $ | 15.4 | $ | 58.1 | $ | 45.2 | ||||||||
Research and development | 0.1 | 0.2 | 0.5 | 0.3 |
September 30, 2018 | December 31, 2017 | |||||||
Accounts payable | $ | — | $ | 5.6 | ||||
Accrued expenses | 7.2 | 5.7 |
Workforce Reductions | ||||
Accrual at December 31, 2017 | $ | 3.4 | ||
Additions | 0.9 | |||
Cash payments | (4.3 | ) | ||
Accrual at September 30, 2018 | $ | — |
Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 | |||||||
Service offerings: | ||||||||
athenaOne | $ | 304.0 | $ | 910.5 | ||||
Other athenahealth-branded services | 8.1 | 25.1 | ||||||
Epocrates | 11.8 | 31.5 | ||||||
Other | 5.6 | 15.1 | ||||||
Total revenue | $ | 329.5 | $ | 982.2 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Net income | $ | 26.4 | $ | 13.0 | $ | 93.9 | $ | 21.5 | ||||||||
Weighted average shares used in computing basic net income per share | 40.5 | 39.9 | 40.4 | 39.8 | ||||||||||||
Net income per share – Basic | $ | 0.65 | $ | 0.33 | $ | 2.32 | $ | 0.54 | ||||||||
Net income | $ | 26.4 | $ | 13.0 | $ | 93.9 | $ | 21.5 | ||||||||
Weighted average shares used in computing basic net income per share | 40.5 | 39.9 | 40.4 | 39.8 | ||||||||||||
Effect of dilutive securities | 0.7 | 0.8 | 0.8 | 0.8 | ||||||||||||
Weighted average shares used in computing diluted net income per share | 41.2 | 40.7 | 41.2 | 40.6 | ||||||||||||
Net income per share – Diluted | $ | 0.64 | $ | 0.32 | $ | 2.28 | $ | 0.53 |
Fair Value Measurements as of September 30, 2018, Using | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Cash and cash equivalents: | ||||||||||||||||
Money market | $ | 0.1 | $ | — | $ | — | $ | 0.1 | ||||||||
Debt securities: | ||||||||||||||||
MDP Accelerator portfolio | — | — | — | — | ||||||||||||
Total assets | $ | 0.1 | $ | — | $ | — | $ | 0.1 | ||||||||
Fair Value Measurements as of December 31, 2017, Using | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Cash and cash equivalents: | ||||||||||||||||
Money market | $ | 0.1 | $ | — | $ | — | $ | 0.1 | ||||||||
Debt securities: | ||||||||||||||||
MDP Accelerator portfolio | — | — | 0.5 | 0.5 | ||||||||||||
Total assets | $ | 0.1 | $ | — | $ | 0.5 | $ | 0.6 |
Fair Value Measurements Using Unobservable Inputs (Level 3) | ||||||||||||||||
Three Months Ended September 30, 2018 | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2018 | Nine Months Ended September 30, 2017 | |||||||||||||
Balance, beginning of period | $ | — | $ | 0.5 | $ | 0.5 | $ | 0.5 | ||||||||
Impairment | — | — | (0.5 | ) | — | |||||||||||
Balance, end of period | $ | — | $ | 0.5 | $ | — | $ | 0.5 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | Total revenue as presented of $329.5 million for the three months ended September 30, 2018. Total revenue under the previous revenue recognition standard of $331.4 million compared to $304.6 million in the same period last year, an increase of 9%. Total revenue as presented of $982.2 million for the nine months ended September 30, 2018. Total revenue under the previous revenue recognition standard of $983.6 million compared to $891.1 million in the same period last year, an increase of 10%. Increased revenue in both the three and nine months ended September 30, 2018 compared to the three and nine months ended September 30, 2017 were the result of strong growth in collections processed driven by continued growth in providers. |
• | Gross margin as presented of 53.1% for the three months ended September 30, 2018. Gross margin under the previous revenue recognition standard of 52.3%, compared to 52.7% in the same period last year. Gross margin as presented of 53.1% for the nine months ended September 30, 2018. Gross margin under the previous revenue recognition standard of 52.0%, compared to 51.5% in the same period last year. |
• | Operating income as presented of $38.2 million for the three months ended September 30, 2018. Operating income under the previous revenue recognition standard of $31.8 million, or 9.6% of total revenue, compared to $18.6 million, or 6.1% of total revenue, in the same period last year. Operating income as presented of $123.4 million for the nine months ended September 30, 2018. Operating income under the previous revenue recognition standard of $100.6 million, or 10.2% of total revenue, compared to $31.9 million, or 3.6% of total revenue, in the same period last year. |
• | Net income as presented of $26.4 million, or $0.64 per diluted share, for the three months ended September 30, 2018. Net income under the previous revenue recognition standard of $21.5 million, or $0.52 per diluted share, compared to net income of $13.0 million, or $0.32 per diluted share, in the same period last year. Net income as presented of $93.9 million, or $2.28 per diluted share, for the nine months ended September 30, 2018. Net income under the previous revenue recognition standard of $76.7 million, or $1.86 per diluted share, compared to net income of $21.5 million, or $0.53 per diluted share, in the same period last year. Our financial results reflect strong revenue growth and continued execution on our plans to reduce expenses and operate more efficiently. |
• | Our balance sheet at September 30, 2018 includes cash and cash equivalents of approximately $303.4 million. Additionally, we have a $500.0 million senior credit facility comprised of a $300.0 million unsecured term loan facility and a $200.0 million unsecured revolving credit facility. As of September 30, 2018, we had $258.8 million outstanding on the unsecured term loan facility and $200.0 million available on the unsecured revolving credit facility. We will continue our disciplined approach to capital allocation decisions, including assessing reinvestments into the business and potential acquisitions, among other potential uses of our assets and available credit. |
• | Net cash provided by operating activities increased $97.5 million in the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. |
• | In June 2018, we announced that our Board of Directors initiated a process to explore strategic alternatives and had begun working with financial advisors. As part of this process, the Board of Directors will consider a sale, merger or other transaction involving the Company as well as continuing as an independent company. |
Three Months Ended September 30, | ||||||||||||||||
2018 | 2017 | |||||||||||||||
As Presented | Impact of New Revenue Standard | Previous Revenue Standard | Previous Revenue Standard | |||||||||||||
(in millions) | ||||||||||||||||
Revenue | $ | 329.5 | $ | 1.9 | $ | 331.4 | $ | 304.6 | ||||||||
Cost of revenue | 154.4 | 3.7 | 158.1 | 144.0 | ||||||||||||
Selling and marketing | 47.6 | 4.6 | 52.2 | 61.8 | ||||||||||||
Income tax provision | 10.0 | 1.5 | 8.5 | 4.2 |
Nine Months Ended September 30, | ||||||||||||||||
2018 | 2017 | |||||||||||||||
As Presented | Impact of New Revenue Standard | Previous Revenue Standard | Previous Revenue Standard | |||||||||||||
(in millions) | ||||||||||||||||
Revenue | $ | 982.2 | $ | 1.4 | $ | 983.6 | $ | 891.1 | ||||||||
Cost of revenue | 460.4 | 11.8 | 472.2 | 432.2 | ||||||||||||
Selling and marketing | 146.2 | 12.4 | 158.6 | 192.5 | ||||||||||||
Income tax provision | 22.7 | 5.6 | 17.1 | 6.1 |
Previous Revenue Standard | ||||||||||||||||||||||||||||
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||||||||||||||
2018 | 2017 | Amount | Percent | 2018 | 2017 | Amount | Percent | |||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||
Business services | $ | 322.7 | $ | 295.8 | 26.9 | 9 | % | $ | 959.6 | $ | 867.1 | 92.5 | 11 | % | ||||||||||||||
Implementation and other | 8.7 | 8.8 | (0.1 | ) | (1 | )% | 24.0 | 24.0 | — | — | % | |||||||||||||||||
Total revenue | $ | 331.4 | $ | 304.6 | 26.8 | 9 | % | $ | 983.6 | $ | 891.1 | 92.5 | 10 | % |
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||||||||||||
2018 | 2017 | Amount | Percent | 2018 | 2017 | Amount | Percent | |||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||
Collections processed | $ | 7,228.7 | $ | 6,487.6 | $ | 741.1 | 11 | % | $21,476.3 | $18,931.7 | $ | 2,544.6 | 13 | % |
Previous Revenue Standard | ||||||||||||||||||||||||||||||
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||||||||||||||||
2018 | 2017 | Amount | Percent | 2018 | 2017 | Amount | Percent | |||||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||||
Cost of revenue | $ | 158.1 | $ | 144.0 | $ | 14.1 | 10 | % | $ | 472.2 | $ | 432.2 | $ | 40.0 | 9 | % |
Previous Revenue Standard | ||||||||||||||||||||||||||||||
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||||||||||||||||
2018 | 2017 | Amount | Percent | 2018 | 2017 | Amount | Percent | |||||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||||
Selling and marketing | $ | 52.2 | $ | 61.8 | $ | (9.6 | ) | (16 | )% | $ | 158.6 | $ | 192.5 | $ | (33.9 | ) | (18 | )% | ||||||||||||
Research and development | 50.9 | 44.8 | 6.1 | 14 | % | 147.5 | 130.0 | 17.5 | 13 | % | ||||||||||||||||||||
General and administrative | 38.4 | 35.4 | 3.0 | 8 | % | 104.7 | 104.5 | 0.2 | — | % | ||||||||||||||||||||
Total | $ | 141.5 | $ | 142.0 | $ | (0.5 | ) | — | % | $ | 410.8 | $ | 427.0 | $ | (16.2 | ) | (4 | )% |
Previous Revenue Standard | ||||||||||||||||||||||||||||
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||||||||||||||
2018 | 2017 | Amount | Percent | 2018 | 2017 | Amount | Percent | |||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||
Income tax provision | $ | 8.5 | $ | 4.2 | $ | 4.3 | * | $ | 17.1 | $ | 6.1 | $ | 11.0 | * | ||||||||||||||
Effective tax rate | 28.3 | % | 24.4 | % | 18.2 | % | 22.1 | % |
Nine Months Ended September 30, | ||||||||||||
2018 | 2017 | Change | ||||||||||
(in millions) | ||||||||||||
Net income | $ | 93.9 | $ | 21.5 | $ | 72.4 | ||||||
Non-cash adjustments | 183.0 | 155.9 | 27.1 | |||||||||
Net income after non-cash adjustments are added back | 276.9 | 177.4 | 99.5 | |||||||||
Cash used in changes in operating assets and liabilities | (18.6 | ) | (16.6 | ) | (2.0 | ) | ||||||
Net cash provided by operating activities | $ | 258.3 | $ | 160.8 | $ | 97.5 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Item 4. | Controls and Procedures |
Item 1. | Legal Proceedings |
Item 1A. | Risk Factors |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. | Defaults Upon Senior Securities |
Item 4. | Mine Safety Disclosures |
Item 5. | Other Information |
Item 6. | Exhibits |
Exhibit No. | Exhibit Description | |
10.1* | Separation Agreement by and between the Registrant and Jonathan Bush dated September 5, 2018. | |
31.1* | Rule 13a-14(a) or 15d-14 Certification of Principal Executive Officer and Chief Financial Officer | |
32.1*^ | Certifications of Principal Executive Officer and Chief Financial Officer pursuant to Exchange Act rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350 | |
101* | XBRL (eXtensible Business Reporting Language). The following materials from athenahealth, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, formatted in XBRL: | |
(i) the Condensed Consolidated Statements of Income and Comprehensive Income | ||
(ii) the Condensed Consolidated Balance Sheets | ||
(iii) the Condensed Consolidated Statements of Cash Flows | ||
(iv) the Notes to Condensed Consolidated Financial Statements |
* | Filed or furnished herewith. |
^ | This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing. |
ATHENAHEALTH, INC. | ||
By: | /s/ Marc A. Levine | |
Marc A. Levine | ||
Principal Executive Officer & Chief Financial Officer |
(a) | continued payment of your annual base salary in effect on the Separation Date for twelve (12) months following the Separation Date (the “Severance Period”), payable in accordance with the Company’s standard payroll practices; provided that, the first payment shall be paid on the next regular Company payday which is at least seven (7) business days after the Effective Date, and shall include payments of any amounts that would be due prior thereto. The “Effective Date” means the eighth (8th) day following your execution of this Agreement without revocation. |
(b) | continued participation in the Company’s group medical and dental plans, at the same cost to you as the cost to an active employee with the same level of coverage as you and your eligible dependents had on the Separation Date, until the earlier of (i) the end of the Severance Period or (ii) the date you become eligible for medical or dental benefits through another employer during the Severance Period; provided, however, that you must timely elect coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, and you must continue to pay the employee portion of the premium costs as well as any applicable administrative fee on time and in full. |
(c) | outplacement services provided through the Company’s third party outplacement services company for up to three (3) months following the Effective Date at a cost to the Company not to exceed $10,000 in the aggregate. |
(a) | In consideration of the terms of this Agreement, on your own behalf, and on behalf of your heirs, executors, administrators, beneficiaries, personal representatives and assigns, you have further agreed to and do release and forever discharge the Company and its subsidiaries and affiliates and their respective past and present officers, directors, shareholders, employees, employee benefit plans, agents, administrators, representatives, successors, and assigns from any and all claims and causes of action, known or unknown, that you have had in the past, now have, or might now have arising out of or relating to your employment by the Company (or any directorship or other affiliation with the Company) or the termination of such employment (or directorship or other affiliation), including, but not limited to wrongful discharge, breach of contract, tort, fraud, defamation and claims under the Civil Rights Acts, the Age Discrimination in Employment Act (the “ADEA”), as amended by the Older Workers Benefit Protection Act, the Americans With Disabilities Act, the Employee Retirement Income Security Act, the Family and Medical Leave Act, Massachusetts Fair Employment Practices Act and the Massachusetts Wage Act and any other federal, state or local law relating to employment, discrimination in employment, termination of employment, wages, benefits or otherwise. |
(b) | This release does not include your right to enforce the terms of this Agreement, your right to receive an award from a Government Agency under its whistleblower program for reporting in good faith a possible violation of law to such Government Agency, your right to coverage or indemnification under the Company’s insurance policies or corporate governance documents, any recovery to which you may be entitled pursuant to Massachusetts’ workers’ compensation and unemployment insurance laws, your right to challenge the validity of this Agreement under the |
(c) | If any claim is not subject to release, to the extent permitted by law, you hereby waive any right or ability to be a class or collective action representative or to otherwise participate in any putative or certified class, collective or multi-party action or proceeding based on such a claim in which any of the Released Parties is a party. |
(a) | Except as otherwise provided in Article VI of the Severance Plan, in the event of any dispute under the provisions of this Agreement or otherwise relating to your employment with the Company, the parties shall have the dispute, controversy or claim settled by confidential arbitration in Massachusetts (or such other location as may be mutually agreed upon by you and the Company) in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association then in effect, before a panel of three arbitrators, one of whom shall be selected by the Company, one of whom shall be selected by you, and the third of whom shall be selected by the other two arbitrators. Any award entered by the arbitrators shall be final, binding and nonappealable and judgment may be entered thereon by either party in accordance with applicable law in any court of competent jurisdiction. This arbitration provision shall be specifically enforceable. The arbitrators shall have no authority to modify any provision of this Agreement or to award a remedy for a dispute involving this Agreement other than a benefit specifically provided under or by virtue of the Agreement. Each party will pay the fees for his, her or its own attorneys, subject to any remedies to which the party may later be entitled under applicable law. However, in all cases where required by law, the Company will pay the arbitrators’ and arbitration fees. If under applicable law the Company is not required to pay all of the arbitrators’ and/or arbitration fees, such fee(s) will be apportioned between the parties by the arbitration panel in accordance with said applicable law, and any disputes in that regard will be resolved by the panel. |
(b) | Any party may seek provisional relief, including temporary restraining orders, temporary protective orders, and preliminary injunctive relief, pending arbitration or in aid of arbitration or both against the other party hereto. Any action seeking such provisional relief pending arbitration or in aid of arbitration shall be brought in the United States District Court for the District of Massachusetts, or if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in the Commonwealth of Massachusetts. The parties consent to the jurisdiction of such courts and to the service of any process, pleadings, notices or other papers in the manner permitted by the notice provisions of Section 18 herein. Each party irrevocably waives any objection which it may now or hereafter have to the laying of the venue of any such suit, action, or proceeding brought in such court and any claim that such suit, action, or proceeding brought in such court has been brought in an inconvenient forum and agrees that service of process in accordance with the foregoing sentences shall be deemed in every respect effective and valid personal service of process upon such party. |
Grant Number | Grant Date | Shares | Price | Outstanding Vested Options Exercisable as of 9/4/2018 | ||
00002753 | 04/01/2010 | 154,000 | $36.78 | 35,000 | ||
00003426 | 04/01/2011 | 75,000 | $44.90 | 44,750 | ||
00004184 | 03/01/2012 | 244,630 | $70.86 | 244,630 | ||
00005579 | 03/01/2013 | 182,000 | $96.09 | 182,000 | ||
00006611 | 03/03/2014 | 100,000 | $195.05 | 100,000 | ||
00007819 | 03/02/2015 | 90,000 | $129.25 | 67,500 |
Date: | November 9, 2018 | /s/ Marc A. Levine | ||
Principal Executive Officer & Chief Financial Officer |
/s/ Marc A. Levine |
Marc A. Levine Principal Executive Officer & Chief Financial Officer |
Document and Entity Information - shares |
9 Months Ended | |
---|---|---|
Sep. 30, 2018 |
Nov. 07, 2018 |
|
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Sep. 30, 2018 | |
Document Fiscal Year Focus | 2018 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | ATHN | |
Entity Registrant Name | ATHENAHEALTH INC | |
Entity Central Index Key | 0001131096 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 40,608,362 |
Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
[1] | Sep. 30, 2018 |
Sep. 30, 2017 |
[1] | ||||||||
Income Statement [Abstract] | |||||||||||||
Revenue | $ 329.5 | $ 304.6 | $ 982.2 | $ 891.1 | |||||||||
Cost of revenue | [2] | 154.4 | 144.0 | 460.4 | 432.2 | ||||||||
Gross profit | 175.1 | 160.6 | 521.8 | 458.9 | |||||||||
Other operating expenses: | |||||||||||||
Selling and marketing | 47.6 | 61.8 | 146.2 | 192.5 | |||||||||
Research and development | [2] | 50.9 | 44.8 | 147.5 | 130.0 | ||||||||
General and administrative | 38.4 | 35.4 | 104.7 | 104.5 | |||||||||
Total other operating expenses | 136.9 | 142.0 | 398.4 | 427.0 | |||||||||
Operating income | 38.2 | 18.6 | 123.4 | 31.9 | |||||||||
Other expense | (1.8) | (1.4) | (6.8) | (4.3) | |||||||||
Income before income tax provision | 36.4 | 17.2 | 116.6 | 27.6 | |||||||||
Income tax provision | 10.0 | 4.2 | 22.7 | 6.1 | |||||||||
Net income | 26.4 | 13.0 | 93.9 | 21.5 | [3] | ||||||||
Foreign currency translation adjustment | (0.7) | (0.1) | (1.5) | 0.3 | |||||||||
Comprehensive income | $ 25.7 | $ 12.9 | $ 92.4 | $ 21.8 | |||||||||
Net income per share - Basic (in dollars per share) | $ 0.65 | $ 0.33 | $ 2.32 | $ 0.54 | |||||||||
Net income per share - Diluted (in dollars per share) | $ 0.64 | $ 0.32 | $ 2.28 | $ 0.53 | |||||||||
Weighted average shares used in computing net income per share: | |||||||||||||
Basic (in shares) | 40.5 | 39.9 | 40.4 | 39.8 | |||||||||
Diluted (in shares) | 41.2 | 40.7 | 41.2 | 40.6 | |||||||||
|
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares |
Sep. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 5,000,000.0 | 5,000,000.0 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 125,000,000.0 | 125,000,000.0 |
Common stock, shares issued (in shares) | 40,600,000 | 40,100,000 |
Common stock, shares outstanding (in shares) | 40,600,000 | 40,100,000 |
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions |
9 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
[2] | ||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||
Net income | $ 93.9 | $ 21.5 | [1] | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization of property, equipment, capitalized software, and purchased intangible assets | 112.0 | 109.3 | ||||||||
Amortization of deferred commissions and contract fulfillment costs | 6.1 | 0.0 | ||||||||
Deferred income tax | 20.0 | 4.2 | ||||||||
Stock-based compensation expense | 38.5 | 42.5 | ||||||||
Other reconciling adjustments | 6.4 | (0.1) | ||||||||
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.5 | (2.2) | ||||||||
Contract assets | (2.5) | 0.0 | ||||||||
Prepaid expenses and other current assets | (16.9) | (8.6) | ||||||||
Deferred commissions and contract fulfillment costs and other long-term assets | (23.9) | (6.8) | ||||||||
Accounts payable | (6.7) | 0.6 | ||||||||
Accrued expenses, deferred rent, and other long-term liabilities | 9.2 | 2.0 | ||||||||
Accrued compensation | 12.0 | (4.0) | ||||||||
Deferred revenue | 7.7 | 2.4 | ||||||||
Net cash provided by operating activities | 258.3 | 160.8 | ||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||
Capitalized software costs | (64.9) | (59.3) | ||||||||
Purchases of property and equipment | (31.9) | (66.8) | ||||||||
Payments on acquisitions, net of cash acquired | (10.1) | (41.1) | ||||||||
Other investing activities | 3.5 | 0.0 | ||||||||
Net cash used in investing activities | (103.4) | (167.2) | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||
Proceeds from issuance of common stock under stock plans | 15.6 | 13.4 | ||||||||
Taxes paid related to net share settlement of stock awards | (15.9) | (17.1) | ||||||||
Payments on long-term debt | (15.0) | (15.0) | ||||||||
Other financing activities | 0.1 | 0.1 | ||||||||
Net cash used in financing activities | (15.2) | (18.6) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | (1.4) | 0.3 | ||||||||
Net increase (decrease) in cash and cash equivalents | 138.3 | (24.7) | ||||||||
Cash and cash equivalents at beginning of period | 165.1 | [3] | 147.4 | |||||||
Cash and cash equivalents at end of period | 303.4 | 122.7 | ||||||||
Non-cash transaction | ||||||||||
Property, equipment, and purchased and internally-developed software recorded in accounts payable, accrued expenses, and accrued compensation | 15.0 | 17.5 | ||||||||
Additional disclosures | ||||||||||
Cash paid for interest, net | 5.0 | 4.5 | ||||||||
Cash paid for taxes | $ 11.6 | $ 1.1 | ||||||||
|
BASIS OF PRESENTATION |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BASIS OF PRESENTATION | BASIS OF PRESENTATION General – The accompanying unaudited condensed consolidated financial statements have been prepared by athenahealth, Inc. (which we refer to as the Company, we, us, or our) in accordance with accounting principles generally accepted in the United States, or GAAP, for interim financial reporting and as required by Regulation S-X, Rule 10-01, and include the results of operations of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP for complete financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of items of a normal and recurring nature) necessary to fairly present the Company's financial position as of September 30, 2018 and December 31, 2017, as indicated above, the results of operations for the three and nine months ended September 30, 2018 and 2017, and cash flows for the nine months ended September 30, 2018 and 2017. The results of operations for the three and nine months ended September 30, 2018 are not necessarily indicative of the results to be expected for the full year. When preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses during the reporting period. Actual results could differ from those estimates, and such differences could be material. We have revised the condensed consolidated statements of cash flows for the nine months ended September 30, 2017 to correct $4.2 million previously reported in the accrued compensation line in operating activities by reclassifying it to the capitalized software costs line in investing activities. This revision had the effect of increasing previously reported net cash provided by operating activities and increasing net cash used in investing activities by $4.2 million each. In June 2018, we announced that our Board of Directors initiated a process to explore strategic alternatives and had begun working with financial advisors. As part of this process, the Board of Directors will consider a sale, merger or other transaction involving the Company, as well as continuing as an independent company. Segment Reporting - In June 2018, our Chief Executive Officer, or CEO, who was also our Chief Operating Decision Maker, or CODM, separated from the Company. Until we appoint a new CEO, our Chairman has been appointed Executive Chairman and our Chief Financial Officer, or CFO, has assumed greater day-to-day operational responsibilities. We have determined that in the interim, our CFO has become our CODM and, as he continues to use consolidated financial information in determining how to allocate resources and assess performance, we continue to operate as a single segment. Recently Adopted Pronouncements Revenue from Contracts with Customers We adopted the new revenue recognition standard on January 1, 2018 using a modified retrospective adoption methodology, whereby the cumulative impact of all prior periods is recorded in retained earnings or other impacted balance sheet line items upon adoption. Under the modified retrospective adoption method, we elected to retroactively adjust, inclusive of all previous modifications, only those contracts that were considered open at the date of initial application. Refer to Note 2 – Revenue and Contract Costs for further information along with our new accounting policies. The aggregation of the adjustments resulted in an adjustment to opening retained earnings as follows:
(1) Adjustment to this line item represents the effect of the new revenue recognition standard adoption on deferred commissions and contract fulfillment costs of $37.7 million and $23.8 million, respectively. The following tables reconcile the balances as presented for the three and nine months ended September 30, 2018 to the balances prior to the adjustments made to implement the new revenue recognition standard for the same periods:
As we ceased amortizing implementation fees under the new revenue recognition standard, we condensed our implementation and other line item into a single revenue line item. The following table disaggregates total revenue into the format previously presented:
Financial Instruments In January 2016, a new accounting standard was issued to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The most significant impact to our consolidated financial statements relates to the recognition and measurement of equity instruments without readily determinable fair values which were previously carried at cost less any impairment determined to be other than temporary. Under the new standard, we measure all equity investments without readily determinable fair values at cost, less impairment, adjusted by observable price changes, such as equity financings, for the same or similar investment from the same issuer. Gains and losses will be recorded in our condensed consolidated statements of income and comprehensive income on a prospective basis. We adopted this accounting standard on January 1, 2018 and there was no impact to our condensed consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2018. On October 22, 2018, we sold a portion of an equity investment for $10.0 million in cash, representing a realized pre-tax gain of $8.9 million. As a result of the observable price change, our remaining holdings of this equity investment have been remeasured to $7.7 million, representing an unrealized pre-tax gain of $6.9 million. Both the realized and unrealized pre-tax gains will be recorded in Other income (expense) within the three months ended December 31, 2018. Related Party Transactions – We have a long-term investment in Access Healthcare Services Private Limited, or Access, a vendor that primarily provides the Company with business process outsourcing services. Our contractual obligations with Access include a purchase obligation that limits our ability to decrease our purchased services from the vendor by more than 33% from the previous calendar year's volume. The tables below present the amounts included within each of the applicable financial statement line items resulting from transactions with our related party:
Exit Costs, Including Restructuring Costs – We previously announced a cost reduction plan in 2017 of which the associated actions were substantially completed as of June 30, 2018. During the three months ended September 30, 2018, we recorded a charge of $0.7 million associated with the plan all of which was recorded in general and administrative. During the nine months ended September 30, 2018, we recorded a charge of $5.3 million associated with the plan, of which $0.8 million was recorded in cost of revenue and $4.5 million was recorded in general and administrative expense, respectively. The activity related to the exit cost accrual related to workforce reductions during the nine months ended September 30, 2018 consists of the following:
Commitments and Contingencies – We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment discrimination claims and challenges to our intellectual property. We believe that we have adequate legal defenses and that the likelihood of a loss contingency relating to the ultimate disposition of any of these disputes is remote. When the likelihood of a loss contingency becomes at least reasonably possible with respect to any of these disputes, or, as applicable in the future, if there is at least a reasonable possibility that a loss exceeding amounts already recognized may have been incurred, we will revise our disclosures in accordance with the relevant authoritative guidance. Additionally, we will accrue a liability for loss contingencies when we believe that it is both probable that a liability has been incurred and that we can reasonably estimate the amount of the loss. We will review these accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained, and our views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. We expense legal costs, including those incurred in connection with loss contingencies, as incurred. New Accounting Pronouncement Not Yet Adopted Leases In February 2016, a new accounting standard was issued for leases. The new standard most significantly impacts lessee accounting and disclosures, but also requires enhanced disclosures for lessors. The new standard requires lessees to record most leases on their balance sheets but recognize the expenses on their statements of income in a manner similar to current accounting guidance. As a lessee, for lease arrangements exceeding a 12-month term, we will recognize a lease liability for the obligation to make lease payments as well as a right-to-use asset for the right to use the underlying asset for the lease term. Leases with a term of 12 months or less will be accounted for similar to the existing standard for operating leases. The new standard is effective for interim and annual periods beginning after December 15, 2018 and will be adopted on a modified retrospective basis. We anticipate that this standard will have a material impact on our consolidated financial statements, as all long-term leases will be capitalized on the condensed consolidated balance sheet. We are in the process of implementing changes to our processes and controls in conjunction with the review of existing lease agreements in connection with the adoption of the new standard on January 1, 2019. We expect that our leases designated as operating leases in Note 8 – Operating Leases included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission, or SEC, on February 1, 2018 will be reported on the consolidated balance sheets upon adoption. Implementation Costs in Cloud Computing Arrangements In August 2018, the Financial Accounting Standards Board issued new accounting guidance to address implementation costs in cloud computing arrangements (hosting arrangements). The new standard requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as an asset and which to expense as incurred. The capitalized implementation costs are to be amortized over the term of the hosting arrangement and be presented in the same line item in the statement of income as the fees associated with the hosting element of the arrangement. The new standard requires the capitalized implementation costs to be presented within the same balance sheet line item as any associated prepaid hosting arrangement fees. Further, the classification of payments for capitalized implementation costs are required to be presented in the same manner as payments of fees for the service component of the hosting arrangement within the statement of cash flows. The new standard is effective for interim and annual periods beginning after December 15, 2019, however, early adoption is permitted. We are evaluating the impact of this accounting standard on our financial statements and related disclosures. |
REVENUE AND CONTRACT COSTS |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVENUE AND CONTRACT COSTS | REVENUE AND CONTRACT COSTS New Revenue Recognition Accounting Policy We derive the majority of our revenue from business services associated with our integrated, network-enabled services. Our integrated athenaOne services for healthcare practices and medical groups and for hospitals and health systems, as well as related standalone services, consist of medical billing and practice management; electronic health records; patient engagement; and order transmission and care coordination, which are supported by our network, athenaNet; we refer to such offerings collectively as athenaOne. We consider the series of services provided under athenaOne to be one performance obligation. Examples of other performance obligations that we have include other athenahealth-branded services such as our population health offering, and those related to supporting athenaOne, including professional services and consulting work, and various services under the Epocrates® brand name. Revenue associated with each of these performance obligations is satisfied and recognized over time, which is typically one month or less. Our clients typically purchase service contracts for our integrated, network-enabled services that renew automatically. In many cases, our clients may terminate their agreements with 90 days’ notice without cause, thereby limiting the term in which we have enforceable rights and obligations, although this time period can vary from client to client. For athenaOne service arrangements, the majority of our fees are variable consideration contingent upon the collections of our clients. We provide value to our clients over the term of the contract, and we recognize revenue ratably over the term, which is consistent with the measure of progress. In the event that we are entitled to variable consideration for services provided during a specified time period, fees for these services are allocated to and recognized over the specified time period. We estimate the variable consideration which we expect to be entitled to over the contractual period associated with our athenaOne contracts, which begins no earlier than go-live, and recognize the fees over the term. The estimate of variable consideration included in the transaction price typically involves estimating the amounts our clients will ultimately collect associated with the services they provide with the assistance of athenaNet and the relative fee we charge associated with those collections. Inputs to these estimates include, but are not limited to, historical service fees, historical collection amounts, the timing of historical collections relative to the timing of when claims are submitted by our clients to their respective payers, macro trends, and trends amongst certain types of similar clients. When reviewing our estimates, in order to ensure that our estimates do not pose a risk of significantly overstating our revenue in any reporting period, we will apply constraints, when appropriate, to certain estimates around our variable consideration. Management will perform analyses periodically to verify the accuracy of our estimates of variable consideration. Disaggregation of Revenue from Contracts with Customers The following table provides information about our revenue by service offering:
New Contract Assets and Deferred Revenue Accounting Policy Due to our go-to-market strategy wherein we do not have a contractual right to bill clients until their collections from various payers are posted to athenaNet, we recognize revenue in advance of our right to payment from our clients. Our clients are billed monthly, in arrears, typically based upon a percentage of collections posted to athenaNet. Amounts recognized as revenue prior to our right to payment are recorded in our contract asset balance. Amounts that we are entitled to collect under the contract are recorded as accounts receivable. Our contract asset balance at September 30, 2018 was $79.9 million. Changes in the contract asset balance primarily consist of increases as a result of providing services that result in additional consideration and are offset by our right to payment for services becoming unconditional. Our deferred revenue balances mainly consist of fees paid by our clients for which the associated services have not been performed. Deferred revenue, which was $32.1 million as of September 30, 2018, primarily relates to our Epocrates services. New Deferred Commissions and Contract Fulfillment Costs Accounting Policies Our sales incentive plans include commissions payable to employees and third parties at the time of initial contract execution that are capitalized as incremental costs to obtain a contract. The capitalized commissions are amortized over the period the related services are transferred including consideration of expected client renewals. As we do not offer commissions on contract renewals, we have determined the amortization period to be the estimated client life, which we have estimated to be 12 years. Deferred commissions were $50.1 million at September 30, 2018 and are included in the other assets line on our condensed consolidated balance sheet. During implementation and prior to go-live, we incur certain contract fulfillment costs primarily related to the configuration of athenaNet for our clients. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and create a resource used to deliver our athenaOne and other athenahealth-branded business services. These costs are amortized over the period the related services are transferred including consideration of expected client renewals, which is based upon our estimate of the client life. Contract fulfillment costs were $35.9 million at September 30, 2018 and are included in the other assets line on our condensed consolidated balance sheet. |
BUSINESS COMBINATIONS |
9 Months Ended |
---|---|
Sep. 30, 2018 | |
Business Combinations [Abstract] | |
BUSINESS COMBINATIONS | BUSINESS COMBINATIONS On May 2, 2018, we acquired a business to enhance our billing and revenue cycle management toolkit by adding contract management and analytics features. The purchase price was $10.1 million, net of cash acquired, that has been allocated primarily to goodwill that is deductible for U.S. income tax purposes. We incurred transaction costs of $0.7 million associated with this acquisition. On June 23, 2017, we acquired Praxify Technologies, Inc., or Praxify, a Palo Alto-based company focused on reinventing how doctors work with health data to help drive productivity, portability, and improved decision support. We acquired Praxify with the goal of advancing our platform strategy and mobile capabilities to drive streamlined workflows and intelligence at and around the moments of care. We anticipate that this acquisition will accelerate our research and development initiatives by adding significant expertise in mobile and user experience design. Additionally, the underlying technology on which Praxify is built is being integrated into our platform, and we anticipate it will create new opportunities for both internal and third-party developers to rapidly build and launch applications. The purchase price of Praxify was $41.1 million, net of cash acquired. The purchase price excludes $16.5 million expected to be earned by key employees of Praxify based upon continued employment, which is accounted for as compensation expense and is being recognized in the condensed consolidated statements of income and comprehensive income over the requisite service period. As of both September 30, 2018 and December 31, 2017, there was $5.5 million of prepaid compensation expense related to retention bonuses made at the time of acquisition included in the prepaid expenses and other current assets line on our condensed consolidated balance sheets; as of September 30, 2018 and December 31, 2017, there was $3.9 million and $8.0 million, respectively, of prepaid compensation expense in the other assets line on our condensed consolidated balance sheets. The fair value of net assets acquired primarily consisted of purchased intangible assets of $15.7 million related to technology. The $33.8 million excess of purchase consideration over the fair value of the net assets acquired was allocated to goodwill, which is not deductible for U.S. income tax purposes. We incurred transaction costs of $1.4 million associated with this acquisition. |
NET INCOME PER SHARE |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NET INCOME PER SHARE | NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted average number of common shares outstanding and potentially dilutive securities outstanding during the period under the treasury stock method. Potentially dilutive securities include stock options, restricted stock units, and shares to be purchased under the employee stock purchase plan. Under the treasury stock method, dilutive securities are assumed to be exercised at the beginning of the periods and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Securities are excluded from the computation of diluted net income per share if their effect would be anti-dilutive to earnings per share; therefore, in periods of net loss, shares used to calculate basic and diluted net loss per share are equivalent. The following table reconciles the weighted average shares outstanding for basic and diluted net income per share for the periods indicated:
The computation of diluted net income per share does not include 0.2 million and 0.3 million shares for both the three and nine months ended September 30, 2018, respectively, and 0.2 million and 0.4 million shares for the three and nine months ended September 30, 2017, respectively, because their inclusion would have an anti-dilutive effect on net income per share. |
FAIR VALUE OF FINANCIAL INSTRUMENTS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | FAIR VALUE OF FINANCIAL INSTRUMENTS As of September 30, 2018 and December 31, 2017, the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximated their estimated fair values because of the short-term nature of these financial instruments. Money market funds are valued using a market approach based upon the quoted market prices of identical instruments when available or other observable inputs such as trading prices of identical instruments in inactive markets or similar securities. Our MDP Accelerator program is designed to cultivate health care information technology start-ups and expand services offered to our provider network. MDP Accelerator portfolio investments and our other direct investments are typically made in the form of convertible notes receivable or equity investments, which are included in other assets on our condensed consolidated balance sheets. During the nine months ended September 30, 2018, we determined the notes receivable were fully impaired and recorded a $0.5 million charge to other expense. As of September 30, 2018 and December 31, 2017, we had $258.8 million and $273.8 million, respectively, outstanding on our term loan facility and we had not drawn on the revolving credit facility under our senior credit facility. The credit facility carries a variable interest rate set at current market rates, which is the primary driver in our conclusion that the carrying value approximates fair value. The following table presents information about our financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2018 and December 31, 2017 and indicates the fair value hierarchy of the valuation techniques we utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices in active markets for identical assets or liabilities, and fair values determined by Level 2 inputs utilize quoted prices in inactive markets for identical assets or liabilities obtained from readily available pricing sources for similar instruments. The fair values determined by Level 3 inputs are unobservable values which are supported by little or no market activity. It is our policy to recognize transfers between levels of the fair value hierarchy, if any, at the end of the reporting period; however, there have been no such transfers during any of the periods presented.
The following table presents our financial instruments measured at fair value using unobservable inputs (Level 3) as of the three and nine months ended September 30, 2018 and 2017:
|
BASIS OF PRESENTATION (Policies) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation | General – The accompanying unaudited condensed consolidated financial statements have been prepared by athenahealth, Inc. (which we refer to as the Company, we, us, or our) in accordance with accounting principles generally accepted in the United States, or GAAP, for interim financial reporting and as required by Regulation S-X, Rule 10-01, and include the results of operations of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP for complete financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of items of a normal and recurring nature) necessary to fairly present the Company's financial position as of September 30, 2018 and December 31, 2017, as indicated above, the results of operations for the three and nine months ended September 30, 2018 and 2017, and cash flows for the nine months ended September 30, 2018 and 2017. The results of operations for the three and nine months ended September 30, 2018 are not necessarily indicative of the results to be expected for the full year. When preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses during the reporting period. Actual results could differ from those estimates, and such differences could be material. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recently Adopted and New Accounting Pronouncements Not Yet Adopted | Recently Adopted Pronouncements Revenue from Contracts with Customers We adopted the new revenue recognition standard on January 1, 2018 using a modified retrospective adoption methodology, whereby the cumulative impact of all prior periods is recorded in retained earnings or other impacted balance sheet line items upon adoption. Under the modified retrospective adoption method, we elected to retroactively adjust, inclusive of all previous modifications, only those contracts that were considered open at the date of initial application. Refer to Note 2 – Revenue and Contract Costs for further information along with our new accounting policies. The aggregation of the adjustments resulted in an adjustment to opening retained earnings as follows:
(1) Adjustment to this line item represents the effect of the new revenue recognition standard adoption on deferred commissions and contract fulfillment costs of $37.7 million and $23.8 million, respectively. The following tables reconcile the balances as presented for the three and nine months ended September 30, 2018 to the balances prior to the adjustments made to implement the new revenue recognition standard for the same periods:
As we ceased amortizing implementation fees under the new revenue recognition standard, we condensed our implementation and other line item into a single revenue line item. The following table disaggregates total revenue into the format previously presented:
Financial Instruments In January 2016, a new accounting standard was issued to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The most significant impact to our consolidated financial statements relates to the recognition and measurement of equity instruments without readily determinable fair values which were previously carried at cost less any impairment determined to be other than temporary. Under the new standard, we measure all equity investments without readily determinable fair values at cost, less impairment, adjusted by observable price changes, such as equity financings, for the same or similar investment from the same issuer. Gains and losses will be recorded in our condensed consolidated statements of income and comprehensive income on a prospective basis. We adopted this accounting standard on January 1, 2018 and there was no impact to our condensed consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2018. On October 22, 2018, we sold a portion of an equity investment for $10.0 million in cash, representing a realized pre-tax gain of $8.9 million. As a result of the observable price change, our remaining holdings of this equity investment have been remeasured to $7.7 million, representing an unrealized pre-tax gain of $6.9 million. Both the realized and unrealized pre-tax gains will be recorded in Other income (expense) within the three months ended December 31, 2018. Related Party Transactions – We have a long-term investment in Access Healthcare Services Private Limited, or Access, a vendor that primarily provides the Company with business process outsourcing services. Our contractual obligations with Access include a purchase obligation that limits our ability to decrease our purchased services from the vendor by more than 33% from the previous calendar year's volume. The tables below present the amounts included within each of the applicable financial statement line items resulting from transactions with our related party:
Exit Costs, Including Restructuring Costs – We previously announced a cost reduction plan in 2017 of which the associated actions were substantially completed as of June 30, 2018. During the three months ended September 30, 2018, we recorded a charge of $0.7 million associated with the plan all of which was recorded in general and administrative. During the nine months ended September 30, 2018, we recorded a charge of $5.3 million associated with the plan, of which $0.8 million was recorded in cost of revenue and $4.5 million was recorded in general and administrative expense, respectively. The activity related to the exit cost accrual related to workforce reductions during the nine months ended September 30, 2018 consists of the following:
Commitments and Contingencies – We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment discrimination claims and challenges to our intellectual property. We believe that we have adequate legal defenses and that the likelihood of a loss contingency relating to the ultimate disposition of any of these disputes is remote. When the likelihood of a loss contingency becomes at least reasonably possible with respect to any of these disputes, or, as applicable in the future, if there is at least a reasonable possibility that a loss exceeding amounts already recognized may have been incurred, we will revise our disclosures in accordance with the relevant authoritative guidance. Additionally, we will accrue a liability for loss contingencies when we believe that it is both probable that a liability has been incurred and that we can reasonably estimate the amount of the loss. We will review these accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained, and our views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. We expense legal costs, including those incurred in connection with loss contingencies, as incurred. New Accounting Pronouncement Not Yet Adopted Leases In February 2016, a new accounting standard was issued for leases. The new standard most significantly impacts lessee accounting and disclosures, but also requires enhanced disclosures for lessors. The new standard requires lessees to record most leases on their balance sheets but recognize the expenses on their statements of income in a manner similar to current accounting guidance. As a lessee, for lease arrangements exceeding a 12-month term, we will recognize a lease liability for the obligation to make lease payments as well as a right-to-use asset for the right to use the underlying asset for the lease term. Leases with a term of 12 months or less will be accounted for similar to the existing standard for operating leases. The new standard is effective for interim and annual periods beginning after December 15, 2018 and will be adopted on a modified retrospective basis. We anticipate that this standard will have a material impact on our consolidated financial statements, as all long-term leases will be capitalized on the condensed consolidated balance sheet. We are in the process of implementing changes to our processes and controls in conjunction with the review of existing lease agreements in connection with the adoption of the new standard on January 1, 2019. We expect that our leases designated as operating leases in Note 8 – Operating Leases included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission, or SEC, on February 1, 2018 will be reported on the consolidated balance sheets upon adoption. Implementation Costs in Cloud Computing Arrangements In August 2018, the Financial Accounting Standards Board issued new accounting guidance to address implementation costs in cloud computing arrangements (hosting arrangements). The new standard requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as an asset and which to expense as incurred. The capitalized implementation costs are to be amortized over the term of the hosting arrangement and be presented in the same line item in the statement of income as the fees associated with the hosting element of the arrangement. The new standard requires the capitalized implementation costs to be presented within the same balance sheet line item as any associated prepaid hosting arrangement fees. Further, the classification of payments for capitalized implementation costs are required to be presented in the same manner as payments of fees for the service component of the hosting arrangement within the statement of cash flows. The new standard is effective for interim and annual periods beginning after December 15, 2019, however, early adoption is permitted. We are evaluating the impact of this accounting standard on our financial statements and related disclosures. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New Contract Assets Accounting Policy | New Revenue Recognition Accounting Policy We derive the majority of our revenue from business services associated with our integrated, network-enabled services. Our integrated athenaOne services for healthcare practices and medical groups and for hospitals and health systems, as well as related standalone services, consist of medical billing and practice management; electronic health records; patient engagement; and order transmission and care coordination, which are supported by our network, athenaNet; we refer to such offerings collectively as athenaOne. We consider the series of services provided under athenaOne to be one performance obligation. Examples of other performance obligations that we have include other athenahealth-branded services such as our population health offering, and those related to supporting athenaOne, including professional services and consulting work, and various services under the Epocrates® brand name. Revenue associated with each of these performance obligations is satisfied and recognized over time, which is typically one month or less. Our clients typically purchase service contracts for our integrated, network-enabled services that renew automatically. In many cases, our clients may terminate their agreements with 90 days’ notice without cause, thereby limiting the term in which we have enforceable rights and obligations, although this time period can vary from client to client. For athenaOne service arrangements, the majority of our fees are variable consideration contingent upon the collections of our clients. We provide value to our clients over the term of the contract, and we recognize revenue ratably over the term, which is consistent with the measure of progress. In the event that we are entitled to variable consideration for services provided during a specified time period, fees for these services are allocated to and recognized over the specified time period. We estimate the variable consideration which we expect to be entitled to over the contractual period associated with our athenaOne contracts, which begins no earlier than go-live, and recognize the fees over the term. The estimate of variable consideration included in the transaction price typically involves estimating the amounts our clients will ultimately collect associated with the services they provide with the assistance of athenaNet and the relative fee we charge associated with those collections. Inputs to these estimates include, but are not limited to, historical service fees, historical collection amounts, the timing of historical collections relative to the timing of when claims are submitted by our clients to their respective payers, macro trends, and trends amongst certain types of similar clients. When reviewing our estimates, in order to ensure that our estimates do not pose a risk of significantly overstating our revenue in any reporting period, we will apply constraints, when appropriate, to certain estimates around our variable consideration. Management will perform analyses periodically to verify the accuracy of our estimates of variable consideration. New Contract Assets and Deferred Revenue Accounting Policy Due to our go-to-market strategy wherein we do not have a contractual right to bill clients until their collections from various payers are posted to athenaNet, we recognize revenue in advance of our right to payment from our clients. Our clients are billed monthly, in arrears, typically based upon a percentage of collections posted to athenaNet. Amounts recognized as revenue prior to our right to payment are recorded in our contract asset balance. Amounts that we are entitled to collect under the contract are recorded as accounts receivable. Our contract asset balance at September 30, 2018 was $79.9 million. Changes in the contract asset balance primarily consist of increases as a result of providing services that result in additional consideration and are offset by our right to payment for services becoming unconditional. Our deferred revenue balances mainly consist of fees paid by our clients for which the associated services have not been performed. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New Deferred Commissions and Contract Fulfillment Costs Accounting Policies | New Deferred Commissions and Contract Fulfillment Costs Accounting Policies Our sales incentive plans include commissions payable to employees and third parties at the time of initial contract execution that are capitalized as incremental costs to obtain a contract. The capitalized commissions are amortized over the period the related services are transferred including consideration of expected client renewals. As we do not offer commissions on contract renewals, we have determined the amortization period to be the estimated client life, which we have estimated to be 12 years. Deferred commissions were $50.1 million at September 30, 2018 and are included in the other assets line on our condensed consolidated balance sheet. During implementation and prior to go-live, we incur certain contract fulfillment costs primarily related to the configuration of athenaNet for our clients. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and create a resource used to deliver our athenaOne and other athenahealth-branded business services. These costs are amortized over the period the related services are transferred including consideration of expected client renewals, which is based upon our estimate of the client life. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income (Loss) per Share | Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted average number of common shares outstanding and potentially dilutive securities outstanding during the period under the treasury stock method. Potentially dilutive securities include stock options, restricted stock units, and shares to be purchased under the employee stock purchase plan. Under the treasury stock method, dilutive securities are assumed to be exercised at the beginning of the periods and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Securities are excluded from the computation of diluted net income per share if their effect would be anti-dilutive to earnings per share; therefore, in periods of net loss, shares used to calculate basic and diluted net loss per share are equivalent. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | As of September 30, 2018 and December 31, 2017, the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximated their estimated fair values because of the short-term nature of these financial instruments. Money market funds are valued using a market approach based upon the quoted market prices of identical instruments when available or other observable inputs such as trading prices of identical instruments in inactive markets or similar securities. Our MDP Accelerator program is designed to cultivate health care information technology start-ups and expand services offered to our provider network. MDP Accelerator portfolio investments and our other direct investments are typically made in the form of convertible notes receivable or equity investments, which are included in other assets on our condensed consolidated balance sheets. |
BASIS OF PRESENTATION (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | The following table disaggregates total revenue into the format previously presented:
The following tables reconcile the balances as presented for the three and nine months ended September 30, 2018 to the balances prior to the adjustments made to implement the new revenue recognition standard for the same periods:
The aggregation of the adjustments resulted in an adjustment to opening retained earnings as follows:
(1) Adjustment to this line item represents the effect of the new revenue recognition standard adoption on deferred commissions and contract fulfillment costs of $37.7 million and $23.8 million, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Related Party Transactions | The tables below present the amounts included within each of the applicable financial statement line items resulting from transactions with our related party:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restructuring Reserve by Type of Cost | The activity related to the exit cost accrual related to workforce reductions during the nine months ended September 30, 2018 consists of the following:
|
REVENUE AND CONTRACT COSTS (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue | The following table provides information about our revenue by service offering:
|
NET INCOME PER SHARE (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | The following table reconciles the weighted average shares outstanding for basic and diluted net income per share for the periods indicated:
|
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table presents information about our financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2018 and December 31, 2017 and indicates the fair value hierarchy of the valuation techniques we utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices in active markets for identical assets or liabilities, and fair values determined by Level 2 inputs utilize quoted prices in inactive markets for identical assets or liabilities obtained from readily available pricing sources for similar instruments. The fair values determined by Level 3 inputs are unobservable values which are supported by little or no market activity. It is our policy to recognize transfers between levels of the fair value hierarchy, if any, at the end of the reporting period; however, there have been no such transfers during any of the periods presented.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following table presents our financial instruments measured at fair value using unobservable inputs (Level 3) as of the three and nine months ended September 30, 2018 and 2017:
|
BASIS OF PRESENTATION - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Oct. 22, 2018 |
Sep. 30, 2018 |
Sep. 30, 2018 |
Sep. 30, 2017 |
||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Reclassification of accrued compensation | $ (12.0) | $ 4.0 | [1] | ||||
Increase in capitalized software costs | (64.9) | (59.3) | [1] | ||||
Increase i net cash used in financing activities | $ (15.2) | (18.6) | [1] | ||||
Limit to decrease purchase services from previous year volume, percent | 33.00% | ||||||
Restructuring charges | $ 0.7 | $ 5.3 | |||||
Workforce Reductions | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Restructuring charges | 0.9 | ||||||
Cost of revenue | Workforce Reductions | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Restructuring charges | 0.8 | ||||||
General and Administrative Expense | Workforce Reductions | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Restructuring charges | $ 4.5 | ||||||
Subsequent Event | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Proceeds from sale of equity investments | $ 10.0 | ||||||
Realized gain from sale of equity investment | 8.9 | ||||||
Remaining holdings of equity investment | 7.7 | ||||||
Subsequent Event | Equity Investments | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Unrealized gain from equity investment | $ 6.9 | ||||||
Restatement Adjustment | |||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
Reclassification of accrued compensation | 4.2 | ||||||
Increase in capitalized software costs | 4.2 | ||||||
Increase i net cash used in financing activities | $ 4.2 | ||||||
|
BASIS OF PRESENTATION - Schedule of Revenue from Contracts with Customers (Details) - USD ($) $ in Millions |
Sep. 30, 2018 |
Jan. 01, 2018 |
Dec. 31, 2017 |
[1] | ||||
---|---|---|---|---|---|---|---|---|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract assets | $ 79.9 | $ 0.0 | ||||||
Deferred tax assets, net | 1.1 | 41.8 | ||||||
Other assets | [2] | 103.9 | 31.3 | |||||
Total assets | 1,589.0 | 1,332.3 | ||||||
Deferred revenue, current | 31.3 | 30.7 | ||||||
Deferred revenue, net of current portion | 0.8 | 46.5 | ||||||
Deferred tax liability, net | 27.6 | 0.0 | ||||||
Retained earnings | 382.2 | 144.8 | ||||||
Total liabilities and stockholders’ equity | 1,589.0 | $ 1,332.3 | ||||||
Deferred Commissions | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract fulfillment costs | 50.1 | |||||||
Contract Fulfillment Costs | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract fulfillment costs | $ 35.9 | |||||||
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09 | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract assets | $ 77.4 | |||||||
Deferred tax assets, net | (40.9) | |||||||
Other assets | 61.5 | |||||||
Total assets | 98.0 | |||||||
Deferred revenue, current | (8.1) | |||||||
Deferred revenue, net of current portion | (44.8) | |||||||
Deferred tax liability, net | 7.4 | |||||||
Retained earnings | 143.5 | |||||||
Total liabilities and stockholders’ equity | 98.0 | |||||||
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09 | Deferred Commissions | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract fulfillment costs | 37.7 | |||||||
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09 | Contract Fulfillment Costs | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract fulfillment costs | $ 23.8 | |||||||
|
BASIS OF PRESENTATION - Schedule of Financial Instruments (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||||
Revenue | $ 329.5 | $ 304.6 | [1] | $ 982.2 | $ 891.1 | [1] | |||||||
Cost of revenue | [2] | 154.4 | 144.0 | [1] | 460.4 | 432.2 | [1] | ||||||
Gross profit | 175.1 | 160.6 | [1] | 521.8 | 458.9 | [1] | |||||||
Other operating expenses: | |||||||||||||
Selling and marketing | 47.6 | 61.8 | [1] | 146.2 | 192.5 | [1] | |||||||
Research and development | [2] | 50.9 | 44.8 | [1] | 147.5 | 130.0 | [1] | ||||||
General and administrative | 38.4 | 35.4 | [1] | 104.7 | 104.5 | [1] | |||||||
Total other operating expenses | 136.9 | 142.0 | [1] | 398.4 | 427.0 | [1] | |||||||
Operating income | 38.2 | 18.6 | [1] | 123.4 | 31.9 | [1] | |||||||
Other expense | (1.8) | (1.4) | [1] | (6.8) | (4.3) | [1] | |||||||
Income before income tax provision | 36.4 | 17.2 | [1] | 116.6 | 27.6 | [1] | |||||||
Income tax provision | 10.0 | 4.2 | [1] | 22.7 | 6.1 | [1] | |||||||
Net income | 26.4 | 13.0 | [1] | 93.9 | 21.5 | [1],[3] | |||||||
Foreign currency translation adjustment | (0.7) | (0.1) | [1] | (1.5) | 0.3 | [1] | |||||||
Comprehensive income | $ 25.7 | $ 12.9 | [1] | $ 92.4 | $ 21.8 | [1] | |||||||
Net income per share - Basic (in dollars per share) | $ 0.65 | $ 0.33 | [1] | $ 2.32 | $ 0.54 | [1] | |||||||
Net income per share - Diluted (in dollars per share) | $ 0.64 | $ 0.32 | [1] | $ 2.28 | $ 0.53 | [1] | |||||||
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09 | |||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||||
Revenue | $ (1.9) | $ (1.4) | |||||||||||
Cost of revenue | (3.7) | (11.8) | |||||||||||
Gross profit | 1.8 | 10.4 | |||||||||||
Other operating expenses: | |||||||||||||
Selling and marketing | (4.6) | (12.4) | |||||||||||
Research and development | 0.0 | 0.0 | |||||||||||
General and administrative | 0.0 | 0.0 | |||||||||||
Total other operating expenses | (4.6) | (12.4) | |||||||||||
Operating income | 6.4 | 22.8 | |||||||||||
Other expense | 0.0 | 0.0 | |||||||||||
Income before income tax provision | 6.4 | 22.8 | |||||||||||
Income tax provision | 1.5 | 5.6 | |||||||||||
Net income | 4.9 | 17.2 | |||||||||||
Foreign currency translation adjustment | 0.0 | 0.0 | |||||||||||
Comprehensive income | $ 4.9 | $ 17.2 | |||||||||||
Net income per share - Basic (in dollars per share) | $ 0.12 | $ 0.42 | |||||||||||
Net income per share - Diluted (in dollars per share) | $ 0.12 | $ 0.42 | |||||||||||
Calculated under Revenue Guidance in Effect before Topic 606 | Accounting Standards Update 2014-09 | |||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||||
Revenue | $ 331.4 | $ 304.6 | $ 983.6 | $ 891.1 | |||||||||
Cost of revenue | 158.1 | 472.2 | |||||||||||
Gross profit | 173.3 | 511.4 | |||||||||||
Other operating expenses: | |||||||||||||
Selling and marketing | 52.2 | 158.6 | |||||||||||
Research and development | 50.9 | 147.5 | |||||||||||
General and administrative | 38.4 | 104.7 | |||||||||||
Total other operating expenses | 141.5 | 410.8 | |||||||||||
Operating income | 31.8 | 100.6 | |||||||||||
Other expense | (1.8) | (6.8) | |||||||||||
Income before income tax provision | 30.0 | 93.8 | |||||||||||
Income tax provision | 8.5 | 17.1 | |||||||||||
Net income | 21.5 | 76.7 | |||||||||||
Foreign currency translation adjustment | (0.7) | (1.5) | |||||||||||
Comprehensive income | $ 20.8 | $ 75.2 | |||||||||||
Net income per share - Basic (in dollars per share) | $ 0.53 | $ 1.90 | |||||||||||
Net income per share - Diluted (in dollars per share) | $ 0.52 | $ 1.86 | |||||||||||
Calculated under Revenue Guidance in Effect before Topic 606 | Accounting Standards Update 2014-09 | Business services | |||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||||
Revenue | $ 322.7 | 295.8 | $ 959.6 | 867.1 | |||||||||
Calculated under Revenue Guidance in Effect before Topic 606 | Accounting Standards Update 2014-09 | Implementation and other | |||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||||
Revenue | $ 8.7 | $ 8.8 | $ 24.0 | $ 24.0 | |||||||||
|
BASIS OF PRESENTATION - Schedule of Related Party Transactions (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
|
Related Party Transaction, Due from (to) Related Party [Abstract] | |||||
Accounts payable | $ 0.0 | $ 0.0 | $ 5.6 | ||
Accrued expenses | 7.2 | 7.2 | $ 5.7 | ||
Cost of revenue | |||||
Related Party Transactions [Abstract] | |||||
Research and development | 21.2 | $ 15.4 | 58.1 | $ 45.2 | |
Research and development | |||||
Related Party Transactions [Abstract] | |||||
Research and development | $ 0.1 | $ 0.2 | $ 0.5 | $ 0.3 |
BASIS OF PRESENTATION - Schedule of Exit Costs, Including Restructuring Costs (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended |
---|---|---|
Sep. 30, 2018 |
Sep. 30, 2018 |
|
Restructuring Reserve [Roll Forward] | ||
Additions | $ 0.7 | $ 5.3 |
Workforce Reductions | ||
Restructuring Reserve [Roll Forward] | ||
Beginning accrual balance | 3.4 | |
Additions | 0.9 | |
Cash payments | (4.3) | |
Ending accrual balance | $ 0.0 | $ 0.0 |
REVENUE AND CONTRACT COSTS - Narrative (Details) - USD ($) $ in Millions |
9 Months Ended | ||||
---|---|---|---|---|---|
Sep. 30, 2018 |
Dec. 31, 2017 |
[1] | |||
Revenue from Contract with Customer [Abstract] | |||||
Period for notice of termination of service contract | 90 days | ||||
Contract assets | $ 79.9 | $ 0.0 | |||
Capitalized Contract Cost [Line Items] | |||||
Deferred revenue | $ 32.1 | ||||
Deferred Commissions | |||||
Capitalized Contract Cost [Line Items] | |||||
Estimated client life | 12 years | ||||
Contract fulfillment costs | $ 50.1 | ||||
Contract Fulfillment Costs | |||||
Capitalized Contract Cost [Line Items] | |||||
Contract fulfillment costs | $ 35.9 | ||||
|
REVENUE AND CONTRACT COSTS - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended |
---|---|---|
Sep. 30, 2018 |
Sep. 30, 2018 |
|
Disaggregation of Revenue [Line Items] | ||
Revenue from contracts with customers | $ 329.5 | $ 982.2 |
athenaOne | ||
Disaggregation of Revenue [Line Items] | ||
Revenue from contracts with customers | 304.0 | 910.5 |
Other athenahealth-branded services | ||
Disaggregation of Revenue [Line Items] | ||
Revenue from contracts with customers | 8.1 | 25.1 |
Epocrates | ||
Disaggregation of Revenue [Line Items] | ||
Revenue from contracts with customers | 11.8 | 31.5 |
Other | ||
Disaggregation of Revenue [Line Items] | ||
Revenue from contracts with customers | $ 5.6 | $ 15.1 |
BUSINESS COMBINATIONS - Narrative (Details) - USD ($) |
9 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
May 02, 2018 |
Jun. 23, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
[1] | Dec. 31, 2017 |
||||||
Business Acquisition [Line Items] | |||||||||||
Purchase price, net of cash acquired | $ 10,100,000 | $ 10,100,000 | $ 41,100,000 | ||||||||
Transaction costs incurred | $ 700,000 | ||||||||||
Goodwill | 281,300,000 | $ 274,400,000 | [2] | ||||||||
Praxify Technologies, Inc. | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Purchase price, net of cash acquired | $ 41,100,000 | ||||||||||
Transaction costs incurred | 1,400,000 | ||||||||||
Continued employment expense | 16,500,000 | ||||||||||
Goodwill | 33,800,000 | ||||||||||
Goodwill, expected tax deductible amount | 0 | ||||||||||
Praxify Technologies, Inc. | Technology-Based Intangible Assets | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Intangible assets acquired | $ 15,700,000 | ||||||||||
Praxify Technologies, Inc. | Prepaid Expenses and Other Current Assets | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Prepaid retention bonuses | 5,500,000 | 5,500,000 | |||||||||
Praxify Technologies, Inc. | Investments and Other Noncurrent Assets | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Prepaid retention bonuses, non-current | $ 3,900,000 | $ 8,000,000 | |||||||||
|
NET INCOME PER SHARE - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|||||||
Earnings Per Share [Abstract] | ||||||||||
Net income | $ 26.4 | $ 13.0 | [1] | $ 93.9 | $ 21.5 | [1],[2] | ||||
Weighted average shares used in computing basic net income per share (in shares) | 40.5 | 39.9 | [1] | 40.4 | 39.8 | [1] | ||||
Net income per share - Basic (in dollars per share) | $ 0.65 | $ 0.33 | [1] | $ 2.32 | $ 0.54 | [1] | ||||
Effect of dilutive securities (in shares) | 0.7 | 0.8 | 0.8 | 0.8 | ||||||
Weighted average shares used in computing diluted net income per share (in shares) | 41.2 | 40.7 | [1] | 41.2 | 40.6 | [1] | ||||
Net income per share - Diluted (in dollars per share) | $ 0.64 | $ 0.32 | [1] | $ 2.28 | $ 0.53 | [1] | ||||
|
NET INCOME PER SHARE - Narrative (Details) - shares shares in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
Earnings Per Share [Abstract] | ||||
Options and restricted stock units which have an antidilutive effect (in shares) | 0.2 | 0.2 | 0.3 | 0.4 |
FAIR VALUE OF FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($) |
9 Months Ended | |
---|---|---|
Sep. 30, 2018 |
Dec. 31, 2017 |
|
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other impairment charges recorded | $ 500,000 | |
Unsecured Debt | Senior Credit Facility, 2015 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term line of credit | 258,800,000 | $ 273,800,000 |
Revolving Credit Facility | Senior Credit Facility | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term line of credit | $ 0 | $ 0 |
FAIR VALUE OF FINANCIAL INSTRUMENTS - Financial Assets and Liabilities that Are Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions |
Sep. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets | $ 0.1 | $ 0.6 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets | 0.1 | 0.1 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets | 0.0 | 0.0 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets | 0.0 | 0.5 |
Money Market Funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents: | 0.1 | 0.1 |
Money Market Funds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents: | 0.1 | 0.1 |
Money Market Funds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents: | 0.0 | 0.0 |
Money Market Funds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents: | 0.0 | 0.0 |
MDP Accelerator portfolio | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities: | 0.0 | 0.5 |
MDP Accelerator portfolio | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities: | 0.0 | 0.0 |
MDP Accelerator portfolio | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities: | 0.0 | 0.0 |
MDP Accelerator portfolio | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities: | $ 0.0 | $ 0.5 |
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Fair Value, Measurements, Recurring - Level 3 - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Balance, beginning of period | $ 0.0 | $ 0.5 | $ 0.5 | $ 0.5 |
Impairment | 0.0 | 0.0 | (0.5) | 0.0 |
Balance, end of period | $ 0.0 | $ 0.5 | $ 0.0 | $ 0.5 |
2Y:_5"7WPZ[
M;K]>QLO%3K\4;V7WM3[_IJ>$@N5BROX/_:Y+@O=,:(QM7;;#_\7VK>WJ:NJ%
MJ%3%S_'S&N F@+4)0#\7P;X4X!_:T P!02W!H130'@)
M&/#NJ-4@?E9TQ6;5U.=%,ZZ?4]$O4TA#FMYMWSC,YO".]&^I]7U#BW+EOO<=
M39B'$8-SS#4B$Q >7&,>.2;PKR&YT$UT@;B4QR49%)/!(5[-XB%6<@=*[$ -
M'?ASCK$AQ@B)!LAQ@$2)DWBS/S/Q,0*\68@GD_)%4CXC%08&J1$2ST8 QZ3!
M,3XXL4PD$(D$G$AX/<@]ARB#QT/ N7K*20RV'*7 L T#8!X1#@-1^
M%!#U =$D !EG.M6/6. L9;1SF/E:+58_1;")9#$+M:EKI]_);+G C&7; F<,44('O[:#C=M#I?ZH8SBX&LDLMBPR&
M$X<7,_9?<.*(/\&0!C1DR""D*P3.+0%R2RV;40(GCLS9CEKVH\!*U[>#C-LQ
M!.D*@7-+@-Q26R]PXLB,32F!$T> 5:YO1PW2>R:['Q&P0[_7XK4./_HT^H.5
MAR2OG# IY 'VP$]6 5$9C ]DNH17PL=
M_[#_)?8V\Q!>? ,T]V5ZKO;WW@CMJ3!6G\,H OS/>FK/_5B&9=R:+$_*/_XR
MK)"4P&96LH/Z[H+'(-Y43NTL ?8%RT_K?_YE5!GHQS3),K5.DX =V%V2 9P$2N?J-C?*F086<1\VIO_:9/E
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M!I*CQ\G](CP5!; 6]NW"H>I0=K6GF=Y>6VG8#RP6[=CX;Q#.QY O37,+<,$
M9HF\%$0S/*SVF?F5Y0G:EN^S-?#XWW]'3#1]#+[[0544*E2&ETD$TB,C]GGR
M@0@PWU;0#SB [$7&&O3>H#\8(O-4P'HVP7MUU!]H0>IM\F62(I5^ &EF]-TL
MVXA$2ZS>K4#V3%%:K6:P9]JZI*> 0\JW35R2=?HFB(:C!I@.!_WCUT!%;PZ?
M?_-9P"=SD!6 .'#TR%4.E@UE9#LIO5AB65,-R"I@7RK((R=T'NA3'2N9?&
M %(#TF6-I_\LDM*BV[\/2FJTF<-K 4KI&&&7LH6+](@;918P->D6:$3EH<2?"'
M:!^T\"C9LK8.MDO*^5J(#G[DA2OQ<"^!& )*.A7]#@.6$8:8<.DZ=YF42>#Z
M(6"8CA")+)Z#VH)R56 .'FP))SV($$?AK_#N,DGFG+:$6K%3:B8812C!*(7<
M'Q,[: ]T2A(I=5O!@2RP^T,1NE62!Y(MTVI*CL&2_1"!!"5+(TO0OMAB%E1&
M-0-$CD()9$O6S8^J!(5O'0$G1_6PP50L.)4'4:E#9T+/3AG(E"+7*1V'00Z^
M8A(U*7:ZB#M"FVCK5FBOO*VC*P(*H$.(S2Q2V3@CAH[738ZK27UD73 *'M%P
ME4*9G#G#8A/2@WUE9*:O?3W)?:@S0/I/8PS4.I/4KS2&J/TSR6VI,T3Z1V\-(<
M//$-T!LQ9Z"D0
]\VZOA^_#"TYIP,M. U:+Q2D7^+ZY
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M2G9.EN29)#M/9)WD9#I., X:+%3P8AGC$=J!-CT*!4CULDLDB4BPO^*%5D
M!=F9Q!BKH=@%SE55(1)B!>8L^,IH).0HUK$4+&3!G!'! BDR0OM0,/=0C:,S
M>J\D6.:0H=KD.9@N2.(->'WO;2R2A36T75K*\C 45M$= ([""O"#+,E(,K@^
M!QD/ISQR&W)1EK 'X"'6J;KU,MQOU7@GNC,EO$PB4PH. V()YXP31I,,D9;R
MLMQL5%8NH7P3,+L#O8K2+"L:&,D0=1&I%8= ASJ'ZWH)**\*80&_*W8'>J%(
M:K=B,^)D(ABG!2]9 [%9 2+V-FD.RF14C91U#4WJ_#J2'(K!J-S,RDV2*A"0P
MN#X+%ZU(7%*(I+W7JJG]8+E2?4 $3HV&FDI,B":.:QJ4%](0S'IL2,PE$X-D
M#4,U17%";ENFU<#C&F4 Y@P!"%R?#, %<(O#]*W=N\;B-ZPG@O\ZNS2 41P<
M?20T!ZHDX\'D)!4)N+B7.8]EMTYF2Z2V!O- 6-[* SDK[Q>,%U)M, !86TR+J58;7'V'M.MT\T1=LZ9Z0N."3PS#E0AJ$I7E
M*H/B0^@9:*/]0?X$[2 GKKDIS#9X;0'_RUA7_>U
M5OCO,KU-HO( 2+X_ZA'NCX3 /ZM]!629;C91GL/'U=R_3.MS NM=O([BN)1D
MF>;P2GC/('W\-]58&!)\+6XJ_[Y):USR8613U(4YJ&Q7_(#L%L8INF?QP^)E
M:*A__O'C+O_^-@RWG[XL[]AJ%[/?UK^RK_9R"4A9@%O\GJ4)_+ADY1%<.UFY
M=V%RR_)?DM/O1,DRVL8LOP;?]8]LV6B%+"Q@=+(+)Z8_ 2;XTW]O]0F])8+K_/-Z.BL[#X:_55]!]P;7X%_[G]\/!WWXL3U)B>Z%
M6G<7?0!?VFD-.Z,_KCJ@H? *0>Q"R/5 <9LK.@9;T.JY*XP5YC0C7%]>@WGH
M?JG2^7G5'G\
7(0EW0E$P1,G;
@A!-!_%L42Q6@K M@*N..EBOB :>0X@0)+'&!
3BXOII\5%\_&%VA8$T^F=Q]
M-KH9C:O+T0\ [=G7JM?#OX>33IIGM3ZW>H.Y%_^ ^CGJCL9(@]E[/G7KA:CZ
ML3-(@%A]L!$8^?[IK.I5[?%PT ?#-7WM$ 1YV!G]Z>RJ->YB(%_U/]]>CL^!
M;ZOAV1A7YBZ[HQ$*/'[
-2/1Q$3#2Y!T@$SCQ:,[C":0S=WP%9 '&K>ZEZ-I(/\)8)H+Y&^C
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M5L!,XN<6*G\;3T]\KM\[CU,#[&_.W-1[S@6&]TD,:'T*KI\36W.8_')$EW;LSW7OHP?"/*@3.
MQF(2)\($Q%G*OV-YX9M !G%4WW!'?=V,VB%6C^)_-1"(QECOM9,/$H]ZB4?-
M3>7:R4>OW6J3@+S6-'73[:S*9JW$2G6(A/4U7YOCB7
5U*DB>)B;ROIF(]N<
MGY0F*J7GHWTBTXM7G *-PCL3E_$*UC8G;A-1F(B8%KI G:JC2*APM-.%MFV8
M'_'6,_J:)X2H8PG=E6,)7TNW&^2B9#*Y,=HPT0F2*PJ,X]D1+6VH$^]E#R],
M]A<9EC9&J[*(IF#F3(ND5'V899D>H:-[6@[0CBI^,L:!LC+6!81+DRPMWQ_4
M2JV4)MEZ_,V]!^%DV.J?=+K=4?NXW3D>]/O.W8/0K?4]" .Z!V%=ANI5 HWH
M0_<@/'(/PMG29+THHM^GN9'XL;!B%58;OGG#:2\#N9"LD_BEGV-YWS-4YWS9!I$>I \2^/\
M"ZTTU#>W@9_.WH]&K?[)2;L[Z/4[G5Y[^&.>+0A"$?*%%._S/];883F)"6Y$_@/R!,
M5D$3/E3]S'+0Z?*NC%57[)[%Z78#+HO9Y83"V/GLAR&:L1CLQIC9[X=!YT+G
MZJPG4R'*^!:&+H8N]@Y=#.>O<J]^Q7.5!.J6E/A
M-WY>IP5$U>DSVS\Q]Y\2E,TF]U
+\"QJNCY/KF&6YBQ1K >RL['M K8>4R9 UBTC;-^ (E!KI8AGQ%&5);
M#'9D!"$((ZN3)9$X"F^B."H>!ET5F9 FQ<6I^<16YUC0G8IW3: 4*#I ??YV
MNS1&21@EM9]"T=3A5ARFX@I3KC#-9,5A'P%%+)?"A*LF7?YQE\8KEN4'B@3C
M!XG]